fda statement bpc-157 not approved warning I think a system such as this could accelerate drug access and approval timelines radically while only exposing the risk tolerant who volunteer. It would make folks who prefer more vetting no Should YOU Be Taking BPC-157
Description
Hepatic Dosing for pediatrics The use of this drug is contraindicated for the treatment of juvenile idiopathic arthritis
this is a community pattern, not a clinical guideline
Wang et al
65 The growth factor binding properties of native sulfated GAGs can be integrated into synthetic scaffold matrices through functionalization with specific chemical groups
